Stock AnalizBath & Body Works, Inc. BBWI
Other Specialty Stores · data as of November 13, 2026
Bath & Body Works, Inc. (BBWI) is a consumer discretionary company listed in the US with a market value of about $4.3B. In the twelve months to August 1, 2026 it had revenue of $7.2B and net income of $781M, a net margin of 10.8%.
Its overall Stock Analiz score is 2.4 out of 5 (weak). The strongest part is shareholder returns (5/5); the weakest is future growth (0/5).
Key numbers: a P/E of 5.6, a price to free cash flow of 4.2, 5-year revenue growth of 3% a year, a 5-year average ROIC of 28%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 121% above the current price.
Score: 2.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- Positive free cash flow
- Pays a dividend
Checks not passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $7.3B | $7.3B | $7.4B | $7.6B | $7.9B | $6.4B | $5.4B | $13.2B | $12.6B | $12.6B |
| Net income | $781M | $649M | $798M | $878M | $800M | $1.3B | $844M | -$366M | $644M | $983M | $1.2B |
| Free cash flow | $1.0B | $865M | $660M | $656M | $816M | $1.2B | $1.8B | $778M | $748M | $699M | $1.0B |
| EPS (diluted) | $3.79 | $3.11 | $3.61 | $3.84 | $3.43 | $4.88 | $3.00 | $-1.32 | $2.31 | $3.42 | $3.98 |
| Net margin | 10.8% | 8.9% | 10.9% | 11.8% | 10.6% | 16.9% | 13.1% | -6.8% | 4.9% | 7.8% | 9.2% |
| ROIC | — | 22.6% | 27.5% | 28.0% | 27.2% | 33.8% | 14.1% | 10.4% | 18.8% | 25.7% | 27.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 15 analysts is $24.53, 15% above the current price; targets range from $17.00 to $54.00; the consensus rating is “Hold”; expected EPS is $2.70 for the fiscal year ending January 31, 2027.
Frequently asked questions
What is Bath & Body Works’s P/E ratio?
About 5.6, based on the last twelve months of diluted earnings per share (forward P/E about 6.6).
Is Bath & Body Works stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 121% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Bath & Body Works pay a dividend?
Yes. The dividend yield is about 3.68%, and it has paid dividends for 10 years in our data.
Is Bath & Body Works a good stock to buy?
We do not give buy or sell advice. Bath & Body Works scores 2.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.